SMS Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals Limited has submitted its standalone/consolidated financial results for the quarter and half-year ended September 30, 2025 to the National Stock Exchange. The headline announcement itself does not include the detailed financial numbers, segment performance, or management commentary. Investors will need to refer to the full results PDF filed with the exchange to evaluate revenue growth, profitability, margins, and any exceptional or one-time items. No audit qualifications, restatements, or going-concern flags are visible from the headline text alone.
The submission is a routine quarterly compliance filing and is not, by itself, a positive or negative catalyst. The actual stock reaction will depend on the numbers inside the results — particularly revenue growth, PAT trajectory, and margin trends versus the previous quarter and year-ago period.